Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
SPECC1L - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
VACTERL Association and Related Disorders Panel PreventionGenetics, part of Exact Sciences United States | 123 | 84 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
PreventionGenetics, part of Exact Sciences United States | 177 | 161 |
|
PreventionGenetics, part of Exact Sciences United States | 156 | 73 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
PreventionGenetics, part of Exact Sciences United States | 7 | 7 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
Genetic Services Laboratory University of Chicago United States | 31 | 35 |
|
Comprehensive Hearing Loss + mtDNA MNG Laboratories (Medical Neurogenetics, LLC.) United States | 218 | 300 |
|
Craniosynostosis (WES based NGS panel of 69 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 69 |
|
Clefting (WES based NGS panel of 231 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 231 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.